アデュカヌマブ (Japanese Wikipedia)

Fox, Cynthia (2015年4月28日). “The Story of Biogen's Alzheimer's Drug, Aducanumab”. Drug Discovery and Development. 2015年7月1日時点のオリジナルよりアーカイブ。2021年6月23日閲覧。

doi.org (Global: 2^nd place; Japanese: 6^th place)

Toyn J (May 2015). “What lessons can be learned from failed Alzheimer's disease trials?”. Expert Review of Clinical Pharmacology 8 (3): 267–9. doi:10.1586/17512433.2015.1034690. PMID 25860157.
Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (September 2016). “The antibody aducanumab reduces Aβ plaques in Alzheimer's disease”. Nature 537 (7618): 50–6. Bibcode: 2016Natur.537...50S. doi:10.1038/nature19323. PMID 27582220.
Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK (October 2020). “Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease”. Curr Neuropharmacol 18 (9): 883–903. doi:10.2174/1570159X18666200429011823. PMC 7569315. PMID 32348223.

fda.gov (Global: 447^th place; Japanese: 1,043^rd place)

fda.gov

“FDA Grants Accelerated Approval for Alzheimer's Drug”. U.S. Food and Drug Administration (FDA) (Press release). 7 June 2021. 2021年6月7日閲覧. この記述には、アメリカ合衆国内でパブリックドメインとなっている記述を含む。
“FDA's Decision to Approve New Treatment for Alzheimer's Disease”. U.S. Food and Drug Administration (FDA) (2021年6月7日). 2021年6月7日閲覧。

accessdata.fda.gov

“Aduhelm (aducanumab-avwa) injection, for intravenous use”. Biogen. 2021年6月8日閲覧。
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761178s003lbl.pdf

forbes.com (Global: 54^th place; Japanese: 269^th place)

Herper, Matthew (2015年3月20日). “Biogen Drug Could Inspire New Hope For Alzheimer's Treatments”. Forbes

gendai.media (Global: 1,760^th place; Japanese: 109^th place)

“悲願「アルツハイマー型認知症新薬」、日本人はまだまだ知らない「理想」と「現実」（村上和巳） @moneygendai”. マネー現代. 2021年7月4日閲覧。

harvard.edu (Global: 18^th place; Japanese: 107^th place)

ui.adsabs.harvard.edu

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (September 2016). “The antibody aducanumab reduces Aβ plaques in Alzheimer's disease”. Nature 537 (7618): 50–6. Bibcode: 2016Natur.537...50S. doi:10.1038/nature19323. PMID 27582220.

icer.org (Global: low place; Japanese: low place)

“ICER Issues Statement on the FDA's Approval of Aducanumab for Alzheimer's Disease”. ICER. 2021年6月11日閲覧。

mainichi.jp (Global: 278^th place; Japanese: 16^th place)

アルツハイマー病新薬、実像は(上) 夢のような根治、期待できず『毎日新聞』朝刊2021年7月22日くらしナビ面（2021年8月15日閲覧）

medicare.gov (Global: low place; Japanese: low place)

What Medicare Part D drug plans cover. US Centers for Medicare & Medicaid Services. Retrieved 14 June 2021.

medscape.com (Global: 719^th place; Japanese: 3,311^th place)

McNamara, Damien (2020年5月28日). “Mixed Results for Aducanumab in Two Phase 3 AD Trials”. Medscape. 2021年6月23日閲覧。
Ault, Alicia (2021年5月5日). “FDA Reviewers: Why We Are Against Approval of Aducanumab for Alzheimer's”. Medscape Medical News. 2021年6月9日閲覧。

newchoicehealth.com (Global: low place; Japanese: low place)

How much does a PET scan cost?. 2018-07-31. New Choice Health. Retrieved 19 June 2021

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

Toyn J (May 2015). “What lessons can be learned from failed Alzheimer's disease trials?”. Expert Review of Clinical Pharmacology 8 (3): 267–9. doi:10.1586/17512433.2015.1034690. PMID 25860157.
Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (September 2016). “The antibody aducanumab reduces Aβ plaques in Alzheimer's disease”. Nature 537 (7618): 50–6. Bibcode: 2016Natur.537...50S. doi:10.1038/nature19323. PMID 27582220.
Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK (October 2020). “Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease”. Curr Neuropharmacol 18 (9): 883–903. doi:10.2174/1570159X18666200429011823. PMC 7569315. PMID 32348223.

pmc.ncbi.nlm.nih.gov

Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK (October 2020). “Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease”. Curr Neuropharmacol 18 (9): 883–903. doi:10.2174/1570159X18666200429011823. PMC 7569315. PMID 32348223.

npr.org (Global: 92^nd place; Japanese: 562^nd place)

nytimes.com (Global: 7^th place; Japanese: 63^rd place)

politico.com (Global: 312^th place; Japanese: 3,157^th place)

New Alzheimer's drug could be 'devastating' for Medicare 06/15/2021. Politico. Retrieved 19 June 2021.

reuters.com (Global: 49^th place; Japanese: 67^th place)

jp.reuters.com

“バイオジェン、アルツハイマー薬の価格を半分に引き下げ”. ロイター (2021年12月20日). 2021年12月21日閲覧。

seekingalpha.com (Global: 5,344^th place; Japanese: low place)

“Biogen CEO: committed to gathering new data on FDA-approved Alzheimer's drug”. 2021年6月23日閲覧。

statnews.com (Global: 8,771^st place; Japanese: low place)

Karlawish, Jason (2021年5月30日). “If the FDA approves Biogen's Alzheimer's treatment, I won't prescribe it”. STAT 2021年6月7日閲覧。
Herper, Matthew (2019年10月22日). “In shocking reversal, Biogen to submit Alzheimer's drug for approval”. STAT. 2019年10月22日閲覧。 “"In one study, called Emerge, patients on the high-dose aducanumab had a 23% reduction in their rate of decline compared to those on placebo; those who were on the low dose were 11% lower than placebo, but that result was not statistically significant. But in the second trial, Engage, the decrease was only 2% in patients on the high dose."”

time.com (Global: 61^st place; Japanese: 289^th place)

Ducharme, Jamie (2019年3月21日). “Biogen Halts Promising Alzheimer's Drug Trials Due to Disappointing Results”. Time. 2019年3月21日閲覧。

washingtonpost.com (Global: 34^th place; Japanese: 255^th place)

web.archive.org (Global: 1^st place; Japanese: 1^st place)

Fox, Cynthia (2015年4月28日). “The Story of Biogen's Alzheimer's Drug, Aducanumab”. Drug Discovery and Development. 2015年7月1日時点のオリジナルよりアーカイブ。2021年6月23日閲覧。

wikipedia.org (Global: low place; Japanese: low place)

en.wikipedia.org

“FDA Grants Accelerated Approval for Alzheimer's Drug”. U.S. Food and Drug Administration (FDA) (Press release). 7 June 2021. 2021年6月7日閲覧. この記述には、アメリカ合衆国内でパブリックドメインとなっている記述を含む。
“FDA's Decision to Approve New Treatment for Alzheimer's Disease”. U.S. Food and Drug Administration (FDA) (2021年6月7日). 2021年6月7日閲覧。
How do drug tiers work?. Blue Cross Blue Shield of Michigan. Retrieved 14 June 2021.
What Medicare Part D drug plans cover. US Centers for Medicare & Medicaid Services. Retrieved 14 June 2021.
“Medicare Copays For New Alzheimer's Drug Could Reach $11,500 Annually”. NPR (2021年6月10日). 2021年6月11日閲覧。
National Coverage Analysis (NCA) for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431N). September 27, 2013. Centers for Medicare & Medicaid Services (CMS). Retrieved 19 June 2021.
New Alzheimer's drug could be 'devastating' for Medicare 06/15/2021. Politico. Retrieved 19 June 2021.

worldcat.org (Global: 5^th place; Japanese: 19^th place)

search.worldcat.org

Belluck, Pam; Robbins, Rebecca (2021年6月10日). “Three F.D.A. Advisers Resign Over Agency's Approval of Alzheimer's Drug”. The New York Times. ISSN 0362-4331 2021年6月14日閲覧。

wsj.com (Global: 79^th place; Japanese: 235^th place)

“FDA Seeks to Probe Talks Between Staff and Biogen on Alzheimer’s Drug／The Food and Drug Administration’s chief is taking the highly unusual step of asking for a federal investigation of doctors within her own agency”Wall Street Journal（Updated July 9, 2021）2021年8月15日閲覧

xconomy.com (Global: low place; Japanese: low place)

Zacks, Rebecca (2007年11月20日). “Biogen Inks $380 Million Deal with Swiss Company”. Xconomy. 2021年6月23日閲覧。

アデュカヌマブ (Japanese Wikipedia)

alz.org (Global: low place; Japanese: low place)

alzfdn.org (Global: low place; Japanese: low place)

alzheimer.ca (Global: low place; Japanese: low place)

apnews.com (Global: 129th place; Japanese: 896th place)

bbc.co.uk (Global: 8th place; Japanese: 73rd place)

bbc.com (Global: 20th place; Japanese: 100th place)

bcbsm.com (Global: low place; Japanese: low place)

biogen.com (Global: low place; Japanese: low place)

investors.biogen.com

bloomberg.com (Global: 99th place; Japanese: 542nd place)

bloomberglaw.com (Global: 5,670th place; Japanese: low place)

news.bloomberglaw.com

bmj.com (Global: 1,226th place; Japanese: 1,988th place)

citizen.org (Global: low place; Japanese: low place)

cms.gov (Global: low place; Japanese: low place)

cnbc.com (Global: 220th place; Japanese: 1,047th place)

cnn.com (Global: 28th place; Japanese: 188th place)

edition.cnn.com

dddmag.com (Global: low place; Japanese: low place)

doi.org (Global: 2nd place; Japanese: 6th place)

fda.gov (Global: 447th place; Japanese: 1,043rd place)

fda.gov

accessdata.fda.gov

forbes.com (Global: 54th place; Japanese: 269th place)

gendai.media (Global: 1,760th place; Japanese: 109th place)

harvard.edu (Global: 18th place; Japanese: 107th place)

ui.adsabs.harvard.edu

icer.org (Global: low place; Japanese: low place)

mainichi.jp (Global: 278th place; Japanese: 16th place)

medicare.gov (Global: low place; Japanese: low place)

medscape.com (Global: 719th place; Japanese: 3,311th place)

newchoicehealth.com (Global: low place; Japanese: low place)

nih.gov (Global: 4th place; Japanese: 24th place)

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

npr.org (Global: 92nd place; Japanese: 562nd place)

nytimes.com (Global: 7th place; Japanese: 63rd place)

politico.com (Global: 312th place; Japanese: 3,157th place)

reuters.com (Global: 49th place; Japanese: 67th place)

jp.reuters.com

seekingalpha.com (Global: 5,344th place; Japanese: low place)

statnews.com (Global: 8,771st place; Japanese: low place)

time.com (Global: 61st place; Japanese: 289th place)

washingtonpost.com (Global: 34th place; Japanese: 255th place)

web.archive.org (Global: 1st place; Japanese: 1st place)

wikipedia.org (Global: low place; Japanese: low place)

en.wikipedia.org

worldcat.org (Global: 5th place; Japanese: 19th place)

search.worldcat.org

wsj.com (Global: 79th place; Japanese: 235th place)

xconomy.com (Global: low place; Japanese: low place)

apnews.com (Global: 129^th place; Japanese: 896^th place)

bbc.co.uk (Global: 8^th place; Japanese: 73^rd place)

bbc.com (Global: 20^th place; Japanese: 100^th place)

bloomberg.com (Global: 99^th place; Japanese: 542^nd place)

bloomberglaw.com (Global: 5,670^th place; Japanese: low place)

bmj.com (Global: 1,226^th place; Japanese: 1,988^th place)

cnbc.com (Global: 220^th place; Japanese: 1,047^th place)

cnn.com (Global: 28^th place; Japanese: 188^th place)

doi.org (Global: 2^nd place; Japanese: 6^th place)

fda.gov (Global: 447^th place; Japanese: 1,043^rd place)

forbes.com (Global: 54^th place; Japanese: 269^th place)

gendai.media (Global: 1,760^th place; Japanese: 109^th place)

harvard.edu (Global: 18^th place; Japanese: 107^th place)

mainichi.jp (Global: 278^th place; Japanese: 16^th place)

medscape.com (Global: 719^th place; Japanese: 3,311^th place)

nih.gov (Global: 4^th place; Japanese: 24^th place)

npr.org (Global: 92^nd place; Japanese: 562^nd place)

nytimes.com (Global: 7^th place; Japanese: 63^rd place)

politico.com (Global: 312^th place; Japanese: 3,157^th place)

reuters.com (Global: 49^th place; Japanese: 67^th place)

seekingalpha.com (Global: 5,344^th place; Japanese: low place)

statnews.com (Global: 8,771^st place; Japanese: low place)

time.com (Global: 61^st place; Japanese: 289^th place)

washingtonpost.com (Global: 34^th place; Japanese: 255^th place)

web.archive.org (Global: 1^st place; Japanese: 1^st place)

worldcat.org (Global: 5^th place; Japanese: 19^th place)

wsj.com (Global: 79^th place; Japanese: 235^th place)